Evidence map›Paper›PMID 37271484›Full record

ReviewAdvances in nutrition (Bethesda, Md.)2023

Cell Survival, Death, and Proliferation in Senescent and Cancer Cells: the Role of (Poly)phenols.

Vincenzo Sorrenti, Alessandro Buriani, Stefano Fortinguerra, Sergio Davinelli, Giovanni Scapagnini, Aedin Cassidy, Immaculata De Vivo

Open access · hybridAbstract readReview
In one paragraph

Review in Advances in nutrition (Bethesda, Md.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Cancers · 2025
    Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Antioxidant and anticancer effects of kiwi (Food science and biotechnology · 2025
    Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 3 countries.

Vincenzo SorrentiDepartment of Pharmaceutical and Pharmacological Sciences, University of Padua, Padua, Italy; Maria Paola Belloni Center for Personalized Medicine, Padova, Italy. Electronic address: vincenzosorrenti88@gmail.com.
Alessandro BurianiMaria Paola Belloni Center for Personalized Medicine, Padova, Italy.
Stefano FortinguerraIRCCS SDN, Napoli, Italy.
Sergio DavinelliDepartment of Medicine and Health Sciences "V. Tiberio," University of Molise, Campobasso, Italy.
Giovanni ScapagniniDepartment of Medicine and Health Sciences "V. Tiberio," University of Molise, Campobasso, Italy.
Aedin CassidyInstitute for Global Food Security, Queen's University Belfast, Belfast, Northern Ireland.
Immaculata De VivoDepartment of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, MA, United States.
University of Molise · ITHarvard University · USQueen's University Belfast · GBSDN Istituto di Ricerca Diagnostica e Nucleare · ITUniversity of Padua · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cellular senescence has long been considered a permanent state of cell cycle arrest occurring in proliferating cells subject to different stressors, used as a cellular defense mechanism from acquiring potentially harmful genetic faults. However, recent studies highlight that senescent cells might also alter the local tissue environment and concur to chronic inflammation and cancer risk by secreting inflammatory and matrix remodeling factors, acquiring a senescence-associated secretory phenotype (SASP). Indeed, during aging and age-related diseases, senescent cells amass in mammalian tissues, likely contributing to the inevitable loss of tissue function as we age. Cellular senescence has thus become one potential target to tackle age-associated diseases as well as cancer development. One important aspect characterizing senescent cells is their telomere length. Telomeres shorten as a consequence of multiple cellular replications, gradually leading to permanent cell cycle arrest, known as replicative senescence. Interestingly, in the large majority of cancer cells, a senescence escape strategy is used and telomere length is maintained by telomerase, thus favoring cancer initiation and tumor survival. There is growing evidence showing how (poly)phenols can impact telomere maintenance through different molecular mechanisms depending on dose and cell phenotypes. Although normally, (poly)phenols maintain telomere length and support telomerase activity, in cancer cells this activity is negatively modulated, thus accelerating telomere attrition and promoting cancer cell death. Some (poly)phenols have also been shown to exert senolytic activity, thus suggesting both antiaging (directly eliminating senescent cells) and anticancer (indirectly, via SASP inhibition) potentials. In this review, we analyze selective (poly)phenol mechanisms in senescent and cancer cells to discriminate between in vitro and in vivo evidence and human applications considering (poly)phenol bioavailability, the influence of the gut microbiota, and their dose-response effects.

Indexed as

NeoplasmsTelomeraseAgingAnimalsCell ProliferationCell SurvivalHumansMammalsPhenolPhenolsPhenolPhenolsTelomeraseantiaginganticancerlongevitypolyphenolssenolyticstelomerasetelomere

Identifiers

PMID37271484
PMCPMC10509428
OpenAlexW4379230965

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.